Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1981 Sep;12(3):327–331. doi: 10.1111/j.1365-2125.1981.tb01221.x

Dissociation of histamine release and clinical improvement following treatment of acquired cold urticaria by prednisone.

A K Black, T M Keahey, R A Eady, M W Greaves
PMCID: PMC1401800  PMID: 6170299

Abstract

1 Corticosteroids are known to suppress evoked histamine release from human skin in vitro. Therefore the effect of prednisone, on cold evoked histamine release and clinical response was studied in six patients with acquired cold urticaria. 2 Following cold challenge all six patients developed an immediate urticarial response of the forearm and elevation of histamine levels, measured by superfusion cascade bioassay of the venous blood draining the forearm. 3 After treatment with prednisone, in an oral dose of 20-25 mg for 1 to 5 days, a suppression of evoked histamine release occurred in all but one patient. However, there was no corresponding decrease of erythema or oedema, though pruritus was improved in most patients. 4 The lack of clinical improvement in erythema and oedema, despite reduction in histamine levels, suggests that histamine may not be the principal mediator of the vascular response to cold challenge in acquired cold urticaria.

Full text

PDF
327

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bentley-Phillips C. B., Black A. K., Greaves M. W. Induced tolerance in cold urticaria caused by cold-evoked histamine release. Lancet. 1976 Jul 10;2(7976):63–66. doi: 10.1016/s0140-6736(76)92285-6. [DOI] [PubMed] [Google Scholar]
  2. Bentley-Phillips C. B., Eady R. A., Greaves M. W. Cold urticaria: inhibition of cold-induced histamine release by doxantrazole. J Invest Dermatol. 1978 Oct;71(4):266–268. doi: 10.1111/1523-1747.ep12515101. [DOI] [PubMed] [Google Scholar]
  3. Curnow J. S. Stable low temperature source to test for cold urticaria. Med Biol Eng Comput. 1978 Mar;16(2):215–216. doi: 10.1007/BF02451925. [DOI] [PubMed] [Google Scholar]
  4. Evans D. P., Lewis J. A., Thomson D. S. An automated fluorimetric assay for the rapid determination of histamine in biological fluids. Life Sci II. 1973 Apr 8;12(7):327–336. doi: 10.1016/0024-3205(73)90366-4. [DOI] [PubMed] [Google Scholar]
  5. GADDUM J. H. The technique of superfusion. Br J Pharmacol Chemother. 1953 Sep;8(3):321–326. doi: 10.1111/j.1476-5381.1953.tb00801.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Granerus G., Svensson S. E., Wetterqvist H., White T. The metabolism of histamine in a case of cold urticaria. Acta Allergol. 1969 Nov;24(4):258–260. doi: 10.1111/j.1398-9995.1969.tb03740.x. [DOI] [PubMed] [Google Scholar]
  7. Greaves M. W., Plummer V. M. Glucocorticoid inhibition of antigen-evoked histamine release from human skin. Immunology. 1974 Sep;27(3):359–364. [PMC free article] [PubMed] [Google Scholar]
  8. Kaplan A. P., Beaven M. A. In vivo studies of the pathogenesis of cold urticaria, cholinergic urticaria, and vibration-induced swelling. J Invest Dermatol. 1976 Sep;67(3):327–332. doi: 10.1111/1523-1747.ep12514352. [DOI] [PubMed] [Google Scholar]
  9. Kaplan A. P., Horáková Z., Katz S. I. Assessment of tissue fluid histamine levels in patients with urticaria. J Allergy Clin Immunol. 1978 Jun;61(6):350–354. doi: 10.1016/0091-6749(78)90113-6. [DOI] [PubMed] [Google Scholar]
  10. Keahey T. M., Greaves M. W. Cold urticaria. Dissociation of cold-evoked histamine release and urticara following cold challenge. Arch Dermatol. 1980 Feb;116(2):174–177. doi: 10.1001/archderm.116.2.174. [DOI] [PubMed] [Google Scholar]
  11. ROSE B. Histamine, hormones, and hypersensitivity. J Allergy. 1954 Mar;25(2):168–189. doi: 10.1016/0021-8707(54)90155-0. [DOI] [PubMed] [Google Scholar]
  12. Schild H. O. A method of conducting a biological assay on a preparation giving repeated graded responses illustrated by the estimation of histamine. J Physiol. 1942 Jun 2;101(1):115–130. doi: 10.1113/jphysiol.1942.sp003970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Soter N. A., Wasserman S. I., Austen K. F. Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge. N Engl J Med. 1976 Mar 25;294(13):687–690. doi: 10.1056/NEJM197603252941302. [DOI] [PubMed] [Google Scholar]
  14. VANE J. R. THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOOD. Br J Pharmacol Chemother. 1964 Oct;23:360–373. doi: 10.1111/j.1476-5381.1964.tb01592.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. WEISSMANN G., THOMAS L. Studies on lysosomes. II. The effect of cortisone on the release of acid hydrolases from a large granule fraction of rabbit liver induced by an excess of vitamin A. J Clin Invest. 1963 May;42:661–669. doi: 10.1172/JCI104757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wasserman S. I., Soter N. A., Center D. M., Austen K. F. Cold urticaria. Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge. J Clin Invest. 1977 Jul;60(1):189–196. doi: 10.1172/JCI108756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Yamamoto S., Greaves M. W., Fairley V. M. Cyclic AMP-induced inhibition of IgE-mediated hypersensitivity in human skin. Immunology. 1973 Jan;24(1):77–83. [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES